Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

SEL-212, an alternative to standard therapy that is administered once monthly, has proven to be particularly helpful for patients with severe gout, a historically underserved population.

Herbert S B Baraf, MD: SEL-212 Novel Combination Therapy for Gout

An announcement from Selecta Biosciences and Sobi provide the latest update on DISSOLVE clinical program, with new data indicating SEL-212 met the primary endpoint of achieving serum urate control during month 6.

Phase 3 DISSOLVE Trials Prove SEL-212's Urate-Lowering Ability in Chronic Gout

Dialysis-dependent patients in the US with gout have an increased risk of cardiovascular comorbidities, hospitalization, and mortality. Results emphasize the need for improved treatments to enhance outcomes for this patient population.

Gout Diagnosis in Dialysis-Dependent Patients Linked to Higher Burden of Cardiovascular Comorbidities, Hospitalization, Mortality

An international pilot study shows a probiotic candidate may improve both management of gout and relevant blood serum levels in treated patients.

Probiotic Linked to Reduced Gout Episodes, Need for Treatment

A brief increase in venous thromboembolism (VTE) was reported within 30 days after a hospitalization or primary care visit for gout flare. The highest incidence occurred during the 16-30 day period after the flare. 



Temporary Increase in Venous Thromboembolism Observed After Gout Flare 

Investigators evaluated the link between gout and thalassemia using data from Taiwan's Longitudinal Health Insurance Database 2000 (LHID 2000).

Incidence of Gout did not Significantly Increase in Patients With Thalassemia 

Of the 23 biomarkers identified in patients with gouty arthritis and hyperuricemia, kynurenic acid, thymine, and phosphatidylinositol (PI) differed from previous gout research. 

Biomarkers may Provide Risk Prediction, Early Diagnosis in Gouty Arthritis 

Patients' perceptions of the effectiveness and necessity of allopurinol for gout treatment proved to be strong factors influencing intentional adherence.




Improving Adherence to Allopurinol: Insights from Patients with Gout

Ginger Hultin, MS, RDN, explained the benefits of an anti-inflammatory nutrition plan for patients living with rheumatic and autoimmune conditions, as well as what rheumatologists need to know. 

Ginger Hultin, MS, RDN: The Role of Anti-Inflammatory Nutrition in Managing Autoimmune, Rheumatic Diseases

An analysis of the DELIVER and DAPA-HF trials provides an overview of the impact of gout on heart failure outcomes and effects of dapagliflozin in this patient population. 

Dapagliflozin Use Reduces Risk in Heart Failure, Need for Uric Acid Lowering in Gout Patients

On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.